NCT01556906View on ClinicalTrials.gov

Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor

PHASE2CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG

Lomitapide

Oral administration with escalating doses administered once daily

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors

Lead Sponsor

Aegerion Pharmaceuticals, Inc.

All Listed Sponsors

collaborator

University of Pennsylvania

OTHER

collaborator

Doris Duke Charitable Foundation

OTHER

lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT01556906 - Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor | Biotech Hunter | Biotech Hunter